?? Facing challenges in Formulation Development and Manufacturing? We’re here to help. At AAPS PharmSci 360 in Salt Lake City next week, we understand the complexities of drug product development—from preformulation to commercial manufacturing. Whether you're dealing with formulation hurdles, scaling challenges, or production timelines, our experts are ready to offer tailored solutions. ?? Booth #2325 – Stop by and chat with our technical and BD teams about how we can support your next product journey, from concept to market, from the US to anywhere in the world ?? Pre-schedule a meeting now: https://buff.ly/4gO6L3o Looking forward to seeing you there! ?? #AAPSPharmSci360 #DrugProductManufacturing #CRDMO #PharmaInnovation #PharmaceuticalDevelopment
关于我们
保诺-桑迪亚是业内领先的合同研究、工艺开发和生产公司(CRDMO),专业为生物制药客户提供全面整合服务,支持药物发现、开发和生产(包括原料药和成品药的商业化生产)。作为全球领先的 CRDMO 公司,保诺-桑迪亚的 10 大办事处遍布全球,旗下拥有 2500 多名员工,在中国和美国开展其主要业务。 保诺-桑迪亚在大小分子发现、开发和放大方面拥有核心专业知识,支持 IND 申报,拥有独特的专利技术平台(例如不溶性化合物生物利用度增强平台)。公司在中国和美国均设有研发中心和生产基地。保诺-桑迪亚采用“一站式”运营模式,有效帮助生物制药客户加快发现进程并降低开发风险,从而创造更高价值的药物。 保诺-桑迪亚由安宏资本领投,Bridgewest Business Group 为共同投资者。 详情请访问:www.bioduro-sundia.com
- 网站
-
https://bioduro-sundia.com/
保诺-桑迪亚的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Irvine,California
- 类型
- 私人持股
- 创立
- 1996
- 领域
- Discovery Chemistry、Integrated Services、Discovery Biology、Protein Expression and Purification、Assay Development、DMPK、Drug Safety Evaluation、Analytical Development、Formulation Development、cGMP Drug Product Manufacturing、In Vivo Oncology、In Vitro Oncology、Immunooncology和Pharmaceutical Research
地点
保诺-桑迪亚员工
动态
-
Ciao Milano, Ciao CPHI. At BioDuro-Sundia we've got you covered. Pick up your umbrella at our booth #5D113 #CPHI2024 #CPHI #DrugDiscovery #DrugSubstance #DrugProduct #CRDMO #Milano #Italy
-
?? Webinar Alert! ?? Do you have molecules in the preclinical stage heading toward IND filing? Join our webinar to learn how to navigate the complexities of early-stage research, regulatory requirements, and compliance. We'll cover key aspects, including ? Generating essential pharmacological and toxicological data ? Optimizing API and formulation R&D and production ? Managing impurity controls ? Streamlining the regulatory submission process ?? Register now! https://bit.ly/3zPyDUs
-
保诺-桑迪亚转发了
ELRIG UK Drug Discovery in London is wrapping up. Thanks to everyone, who dropped by BioDuro-Sundia's booth! Including Graham Combe #coffeebuddies Our team along with Jafarkhan Kottrayil, Paul B., and Lin Teng enjoyed the two days filled with #drugdiscovery insights presented over four parallel tracks. #elrig #elrigdd24 Next stop: Milan ???? see you at #CPHI next week!
-
?? Congratulations to our talented scientist, Bhavishya Mittal, on the publication of another new book! ?? At BioDuro-Sundia, we are incredibly proud of Bhavi and the many brilliant scientists who work alongside him. His achievement is a testament to the strength of our scientific team, whose expertise in new drug product development is making a global impact. We are honored to have such dedicated and inspiring individuals on our team, working with our global partners toward a common goal: improving lives and advancing healthcare for patients around the world. #BioDuroSundia #DrugDevelopment #DrugProduct #Formulation #OSD #Phamraceutical
-
Breaking: BioDuro-Sundia Launches New Compound Management Center! ?? We are excited to announce the opening of our new Compound Management Center at the Waigaoqiao site in Shanghai Free-Trade Zone! It gives our customers complete peace of mind that their compounds are securely stored, their inventories are meticulously tracked and updated in real-time, and their samples are readily accessible for quick delivery. We are committed to supporting new drug R&D needs with precision and reliability. Learn more: https://lnkd.in/dQCQTwp8 #DrugDiscovery #CDMO #Innovation #Healthcare #NewTherapies #CompoundManagement
-
?? We're heading to CPHI in Milan! From October 8-10, our team of experts will be at CPHI, ready to showcase how we deliver comprehensive solutions across drug substance and drug product development. ?? Visit us at Booth #5D113 to learn more about: ? Drug Substance: Small Molecules, Oligonucleotides / Peptides, Antibody-Drug Conjugates ? Drug Product: Bioavailability Solutions: HME / SDD, Controlled and Modified Release, “Solution Engine” for Fast IND Filings Our team is excited to connect with industry leaders, discuss your needs, and explore how we can help bring your innovations to market faster. Let's collaborate to create better treatments for patients around the globe. ???? To pre-schedule a meeting, please click here: https://buff.ly/4gO6L3o #CPHI2024 #DrugDevelopment #PharmaManufacturing #Biotech #DrugSubstance #DrugProduct #Formulation #Manufacturing
-
?? Service Spotlight: Your Trusted CDMO Partner for Formulation Development & Manufacturing Are you in search of a reliable CDMO for formulation and drug product development? Since 1996, we’ve been pioneers in HME for bioavailability enhancement. We support every stage of the drug development lifecycle—from preformulation to formulation development, and clinical through commercial manufacturing at our sites in Irvine, CA, USA and Jiangsu, China. In addition to bioavailability technologies such as SDD and HME, we also specialized in tailored release profiles, including Immediate Release (IR), Modified Release (MR), and Extended Release (ER). ?? Meet our expert technical team at these upcoming industry events to discuss how we can support your drug product needs. Preschedule a meeting here: https://buff.ly/4gAI9LB
-
Breaking News! We are thrilled to welcome Dr. Armin Spura as our new CEO! ?? With over 20 years of experience in life sciences and a proven track record of driving growth and innovation, Dr. Spura's leadership is set to accelerate our mission to deliver better treatments to patients worldwide. Join us in celebrating this new chapter and stay tuned for more updates as we continue to innovate and expand our CRDMO platform! ?? #Leadership #LifeSciences #Biotech #Pharma #CRDMO #Innovation #Growth #BioDuroSundia
-
?Attending ISSX meeting (International Society for the Study of Xenobiotics) in sunny Hawaii? ?? Talk to our experts about how BioDuro-Sundia can support your translational xenobiotic research. With 28 years of experience, we provide a range of in vivo PK/TK, in vitro ADME, and bioanalytical services, empowering hundreds of customers every year. To learn more, read about our DMPK capabilities in the flyer or visit our website: https://lnkd.in/gNJAeKka #DMPK #CDMO